Atg4D Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Autophagy Related 4D Cysteine Peptidase | |
|---|---|
| Gene Symbol | ATG4D |
| Full Name | Autophagy Related 4D Cysteine Peptidase |
| Chromosome | 19p13.3 |
| NCBI Gene ID | 84939 |
| OMIM | 618063 |
| Ensembl ID | ENSG00000125844 |
| UniProt ID | Q9GZM8 |
| Associated Diseases | Neurodegeneration, Cancer, Metabolic Disorders |
ATG4D (Autophagy Related 4D Cysteine Protease) is a member of the ATG4 protease family that processes LC3 family proteins during autophagosome biogenesis. While ATG4C is the most studied ATG4 isoform, ATG4D also contributes to autophagy regulation with tissue-specific expression patterns. ATG4D possesses protease activity that cleaves the C-terminal arginine from LC3/GABARAP proteins, enabling subsequent lipidation and incorporation into the growing autophagosome membrane.
In the context of neurodegenerative diseases, ATG4D supports cellular quality control mechanisms through autophagy. The enzyme helps maintain neuronal health by facilitating degradation of damaged mitochondria (mitophagy) and protein aggregates. Dysregulation of ATG4D and other autophagy-related proteins contributes to the accumulation of toxic protein inclusions in Alzheimer's, Parkinson's, and Huntington's diseases. Therapeutic modulation of ATG4D activity may enhance autophagic flux and reduce neurotoxic protein burden.
ATG4D encodes a cysteine protease involved in autophagy, the fourth member of the ATG4 family (ATG4A-D). Like other ATG4 proteases, ATG4D processes LC3/GABARAP family proteins by cleaving their C-terminal arginine or glycine residues. ATG4D has a more restricted substrate specificity compared to ATG4B. It plays roles in both canonical autophagy and non-canonical functions including DNA damage response. ATG4D expression is regulated by stress conditions and may have tissue-specific functions.
Lower expression compared to other ATG4 homologs. Expressed in brain, heart, and other tissues. Induced under stress conditions.
| Disease | Variants | Inheritance | Mechanism |
|---|---|---|---|
| Neurodegeneration | Variants | Risk factor | Impaired autophagy |
| Cancer | Variants | Context-dependent | Autophagy dysregulation |
| Metabolic disorders | Variants | Risk factor | Altered metabolism |
The study of Atg4D Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.